Institute of Immunology and Immunotherapy Immunology is at the forefront of medical research and we are among the leaders of this exciting, fast-evolving field.
COVID-19 News New study finds strong immune response following COVID-19 vaccination A new study carried out in collaboration with the University of Birmingham with support from the UK Coronavirus Immunology Consortium has found that 99% of people generate a robust immune response against COVID-19 after just one dose of the Pfizer vaccine.
COVID-19 New gene therapy innovation centre to advance scientific discoveries into life-changing treatments
23 March 2020 The development of more accurate antibody tests for SARS-CoV-2 is crucial and urgent Work to develop tests to detect COVID-19 antibodies is urgent and critically important. Research at universities will be crucial in finding a solution to the current crisis, a University of Birmingham expert has said.
12 March 2020 Five-year MRC programme grant awarded to University researchers Professor Graham Anderson and his team have been successful in renewing their MRC programme grant 'Targeting New Mechanisms In The Control Of Thymus Function To Restore Balanced T-cell Production'.
20 February 2020 Birmingham named one of just six new Life Sciences Opportunity Zones The Birmingham Health Partners ecosystem has been awarded Life Sciences Opportunity Zone status by the Department for Business, Energy and Industrial Strategy.
13 February 2020 Scientists uncover new understanding of how antibodies target dangerous bacteria A new study from the University of Birmingham has helped provide novel understanding into how to select antigens to target in vaccines or new treatments against bacterial infections.
04 February 2020 Birmingham researcher awarded £1.4 million CRUK Advanced Clinician Scientist Fellowship Dr Shishir Shetty has been awarded a £1.4 million Advanced Clinician Scientist Fellowship from Cancer Research UK to further his research into liver cancer.
19 November 2019 BSI Tumour Immunology Group Professor Ben Willcox from the University of Birmingham's Institute of Immunology and Immunotherapy writes for the British Society of Immunology on the UK-wide Tumour Immunology Group.
19 November 2019 Researchers discover new target recognised by T cells involved in gut immunosurveillance Researchers in the University of Birmingham's Institute of Immunology and Immunotherapy have discovered a new target recognised by local T-cells involved in immunosurveillance in the gut.
11 November 2019 Experts to gather in Africa to speed up development of vaccines to prevent bacterial infections A global network of scientists who are working together to accelerate the development of vaccines against bacterial infections in low and middle income countries are to stage an annual network meeting in Africa.
30 October 2019 New collaborative learning hub helps bridge the gap between medicine and engineering The Clinician Engineer Hub aims to educate medical students and early career doctors about the diagnostic and treatment challenges in clinical medicine.
29 October 2019 Senior Clinical Lecturer joins Institute of Immunology and Immunotherapy Dr Leila Khoja joins Birmingham from AstraZeneca and Addenbrooke's Hospital, bringing with her an extensive experience in translating immunotherapies from bench to bedside.
25 October 2019 Researchers at University of Birmingham awarded over £1 million for latest technology for immune regulation Researchers at the University of Birmingham awarded £1.15 million for latest equipment for immune regulation.
03 October 2019 New partnership aims to identify new disease mechanisms and potential targets for treatment of non-alcoholic fatty liver disease A new partnership between scientists at the University of Birmingham and global healthcare company Novo Nordisk aims to discover new treatments for people suffering from fatty liver disease.